Fibrocystic disease in women receiving oral contraceptive hormones

Breast tissue with the diagnosis of fibrocystic disease has been examined from 25 women taking oral contraceptives. Slides from these cases were coded and mixed with slides from patients of the same ages having fibrocystic disease who denied hormone usage. Various epithelial alterations were tabulated without knowledge of hormone therapy. The patients receiving oral contraceptive hormones presented a spectrum of epithelial alterations qualitatively and quantitatively similar to their controls. Neither specific nor bizarre epithelial alterations were recognized.